The Role of Apoptosis in Pituitary Adenomas in the Field of Conventionally Used Therapeutic Approaches

Annals of the New York Academy of Sciences

Volumn 1010, Issue , 2003, Pages 520-524

  Cerman, Jaroslav ^a   Cap, Jan ^a   Marekova, Martina ^a   Nemecek, Stanislav ^a   Marek, Josef ^a   Rudolf, Emil ^a   Cervinka, Miroslav ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Acromegaly; Apoptosis; Cell lines; Irradiation; Pituitary adenomas; Somatostatin analogues

Indexed keywords

GROWTH HORMONE; KI 67 ANTIGEN; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE;

APOPTOSIS; BRAIN SURGERY; CANCER CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IONIZING RADIATION; LABELING INDEX; LATENT PERIOD; MITOSIS INHIBITION; MOUSE; NONHUMAN; RADIATION DOSE; RAT; VASCULAR FIBROSIS;

EID: 1342284262     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1299.096     Document Type: Conference Paper

References (5)

1. FREDA, P.U. 2002. Somatostatin analogs in acromegaly. J. Clin. Endocrinol. Metab. 87: 3013-3018.
2. NEWMAN, C.B., S. MELMED, A. GEORGE, et al. 1998. Octreotide as primary therapy for acromegaly. J. Clin. Endocrinol. Metab. 83: 3034-3040.
3. AMATO, G., G. MAZZIOTTI, M. ROTONDI, et al. 2002. Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. Clin. Endocrinol. (Oxford) 56: 65-71.
4. VLADYKA, V., R. LISCAK, G. SIMONOVA, et al. 2000. Gamma Knife (GK) radiosurgery for pituitary adenomas: evaluation of a series of 163 patients. J. Radiosurgery 3: 113-131.
5. LANDOLT, A.M., D. HALLER, N. LOMAX, et al. 2000. Octreotide may act as a radioprotective agent in acromegaly. J. Clin. Endocrinol. Metab. 85(3): 1287-1289.